Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Endothelin antagonists described by Bristol-Myers Squibb

Oct. 29, 1997

No Comments

Alexion reports phase I/II and IIa results for C5 inhibitor

Oct. 28, 1997

No Comments

Flamel Technologies reports clinical results on Asacard

Oct. 27, 1997

No Comments

SmithKline Beecham to copromote Teveten with HMR

Oct. 23, 1997

No Comments

Novel angiotensin II antagonists for hypertension/CHF

Oct. 23, 1997

No Comments

Abbott describes new endothelin antagonists

Oct. 23, 1997

No Comments

Fujirebio cardiovascular agent advances to phase II

Oct. 23, 1997

No Comments

Biovail and Technilab Pharma sign marketing agreement

Oct. 23, 1997

No Comments

German launch for Roche's mibefradil

Oct. 22, 1997

No Comments

Atlantic's sulfated cyclodextrins effective in preclinical models of restenosis

Oct. 21, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Cardiovascular
RSS

Endothelin antagonists described by Bristol-Myers Squibb

Alexion reports phase I/II and IIa results for C5 inhibitor

Flamel Technologies reports clinical results on Asacard

SmithKline Beecham to copromote Teveten with HMR

Novel angiotensin II antagonists for hypertension/CHF

Abbott describes new endothelin antagonists

Fujirebio cardiovascular agent advances to phase II

Biovail and Technilab Pharma sign marketing agreement

German launch for Roche's mibefradil

Atlantic's sulfated cyclodextrins effective in preclinical models of restenosis

Today's news in brief

Today's news in brief

STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space

Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance

Australia’s Celosia heads toward clinic with gene therapy for ALS

Cardiovascular RSS

Cardiovascular
RSS